The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

Pennsylvania Attorney General Dave Sunday has announced that a bipartisan coalition including states and other entities have agreed, in principle, to a $7.4 billion settlement with Purdue Pharma and ...

Varadkar has been named as the Hauser Leader of the Harvard Kennedy School Center for Public Leadership for its spring ...

A GoLocal investigation explores how CVS and its then-President Helena Foulkes often told one story about opioids while the company profited, and she made tens of millions in salary, stock incentives, ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

The billionaire family that owns Purdue Pharma ... saga involving the pharmaceutical company that earned billions of dollars from the blockbuster painkiller OxyContin as sales representatives ...

Purdue Pharma and the members of the Sackler family ... The deal, negotiated by a bipartisan team, is subject to court approval, and attorneys said more details need to be finalized in the coming ...

Get Wall Street's Hottest Chart Every Morning What Happened: Purdue Pharma developed and aggressively marketed OxyContin starting in the 1990s via medical sales reps whose job was to convince ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...